Expression of microRNA21 in human periodontal ligament cells osteogenic differentiation

doi:10.3877/cma.j.issn.1674-1366.2015.01.002

Abstract

Abstract:

Objective

To investigate the expression of microRNA21 (miR21) and explore its function and possible mechanism during osteogenic differentiation in human periodontal ligament cells (PDLCs) .

Methods

PDLCs were isolated from human periodontal ligament tissue and immuncytochemical staining was used to identify their origin. Cells from the 3rd to 4th passage were cultivated in mineralizing medium for 7 days, 14 days and 21 days respectively. Alkaline phosphatase (ALP) experiment and alizarin red (AR) staining were used to identify osteogenic differentiation capacity of PDLCs. The cells were cultured for 4 hours, 1 day, 3 days and 7 days respectively. Expression of miR21, Sprouty 2 (SPRY2) and Runx2 were tested by quantitative real-time PCR and the phosphorylated ERK1/2, phosphorylated p38, SPRY2 and Runx2 were measured by western blot. Cells without osteogenic induction served as controls.

Results

The cultured PDLCs were derived from mesenchyma. Compared to the control groups, AR staining showed obvious mineralization nodules, and ALP activities were significantly higher in 7 d-, 14 d- and 21 d-osteogenic induction groups (P < 0.05) . MiR21 started up-regulate since 3rd day, and remained high expressed level until 7 days in osteogenic induction groups. Expression of SPRY2 reversed to which of miR21 in the induction groups. The results of western blot showed that both ERK-MAPK and p38 MAPK pathway were activated. ERK-MAPK pathway was activated since the 1st day and sustained during the early osteogenesis period of PDLCs. At the 4th hour of induction, the activity of p38 MAPK was obviously enhanced, then returned to which of the control groups, and up regulated again at 7 days of mineralization cultivation.

Conclusions

MiR21 was related to osteogenic differentiation of PDLCs and probably modulated ERK-MAPK and p38 MAPK pathways. MiR21 might target SPRY2 as a regulator of ERK-MAPK pathway during osteogenic differentiation of PDLCs. This result can provide basis for further research on its fine mechanism.

Key words: MicroRNA21, Periodontal ligament cells, Osteogenic differentiation, Mitogen-activated protein kinases signaling pathway

Jinxuan Zheng, Lixiang Mai, Lu Liu, Hong Hong, Xiaomin Chen, Liping Wu. Expression of microRNA21 in human periodontal ligament cells osteogenic differentiation[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2015, 09(01): 7-13.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhkqyxyjzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-1366.2015.01.002

https://zhkqyxyjzz.cma-cmc.com.cn/EN/Y2015/V09/I01/7

Figures/Tables 4

References 18

[1]	Mei Y, Bian C, Li J，et al. miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation[J]. J Cell Biochem，2013，114(6):1374-1384.
[2]	Perdiguero E, Sousa-Victor P, Ruiz-Bonilla V，et al. p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair[J]. J Cell Biol，2011，195(2):307-322.
[3]	洪弘，郑金绚，吴莉萍，等.牙周膜相关蛋白1在人牙周膜细胞成骨分化过程中的表达[J].中华口腔医学研究杂志：电子版，2013，7(6):453-459.
[4]	Li C, Li C, Yue J，et al. miR-21 and miR-101 regulate PLAP-1 expression in periodontal ligament cells[J]. Mol Med Rep，2012，5(5):1340-1346.
[5]	Seo BM, Miura M, Gronthos S，et al. Investigation of multipotent postnatal stem cells from human periodontal ligament[J]. Lancet，2004，364(9429):149-155.
[6]	Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease[J]. RNA Biol，2011，8(5):706-713.
[7]	Ge C, Xiao G, Jiang D，et al. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development[J]. J Cell Biol，2007，176(5):709-718.
[8]	Yang N, Wang G, Hu C，et al. Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis[J]. J Bone Miner Res，2013，28(3):559-573.
[9]	Eguchi T, Watanabe K, Hara ES，et al. OstemiR：A novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells[J]. PLoS One，2013，8(3):e58796.
[10]	He L, Yang N, Isales CM，et al. Glucocorticoid-induced leucine zipper（GILZ）antagonizes TNF-α inhibition of mesenchymal stem cell osteogenic differentiation[J]. PLoS One，2012，7(3):e31717.
[11]	Greenblatt MB, Shim JH, Glimcher LH. Mitogen-activated protein kinase pathways in osteoblasts[J]. Annu Rev Cell Dev Biol，2013(29):63-79.
[12]	Lee KS, Hong SH, Bae SC. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein[J]. Oncogene，2002，21(47):7156-7163.
[13]	Greenblatt MB, Shim J H, Zou W，et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice[J]. J Clin Invest，2010，120(7):2457-2473.
[14]	Guy GR, Jackson RA, Yusoff P，et al. Sprouty proteins：modified modulators，matchmakers or missing links?[J]. J Endocrinol，2009，203(2):191-202.
[15]	Whelan JT, Hollis SE, Cha DS，et al. Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway[J]. J Cell Physiol，2012，227(3):1235-1241.
[16]	Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21[J]. Chin J Cancer，2011，30(6):371-380.
[17]	Wescott DC, Pinkerton MN, Gaffey BJ，et al. Osteogenic gene expression by human periodontal ligament cells under cyclic tension[J]. J Dent Res，2007，86(12):1212-1216.
[18]	Wang Y, Li Y, Fan X，et al. Early proliferation alteration and differential gene expression in human periodontal ligament cells subjected to cyclic tensile stress[J]. Arch Oral Biol，2011，56(2):177-186.

基因	引物序列	产物大小（bp）
miR21	F:5 ′ -ACACTCCAGCTGGGTAGCTTATCAGACTGATG-3 ′	72
?	R:5 ′ -CTCAACTGGTGTCGTGGA-3 ′	?
SPRY2	F:5 ′ -CGATTGCTCGGAAGTTGGTC-3 ′	163
?	R:5 ′ -TCCAGCAGGCTTAGAACACA-3 ′	?
RUNX2	F:5 ′ -GATGGTACGGTGGTGACTGT-3 ′	160
?	R:5 ′ -CAGTGATGGTCAGGGTGAAA-3 ′	?

基因	引物序列	产物大小（bp）
miR21	F:5 ′ -ACACTCCAGCTGGGTAGCTTATCAGACTGATG-3 ′	72
?	R:5 ′ -CTCAACTGGTGTCGTGGA-3 ′	?
SPRY2	F:5 ′ -CGATTGCTCGGAAGTTGGTC-3 ′	163
?	R:5 ′ -TCCAGCAGGCTTAGAACACA-3 ′	?
RUNX2	F:5 ′ -GATGGTACGGTGGTGACTGT-3 ′	160
?	R:5 ′ -CAGTGATGGTCAGGGTGAAA-3 ′	?

Please choose a citation manager

Content to export